8-K/A

FORM 8-K AMENDMENT NO. 1

Company: Oruka Therapeutics, Inc.
Filed: December 27, 2011
Period of Report: December 22, 2011
Accession Number: 0001193125-11-352704

View Document ↗ View on SEC.gov ↗